Drug – bio-affecting and body treating compositions – Extract – body fluid – or cellular material of undetermined... – Blood
Reexamination Certificate
2006-10-24
2006-10-24
Saucier, Sandra E. (Department: 1651)
Drug, bio-affecting and body treating compositions
Extract, body fluid, or cellular material of undetermined...
Blood
C435S217000
Reexamination Certificate
active
07125569
ABSTRACT:
A method for specifically removing or isolating plasmin(ogen) or plasmin in presence of fibrinogen from a mixture containing plasmin(ogen) or plasmin by contacting the mixture with a rigid amino acid wherein the amino group of the amino acid and the carboxylic group of the amino acid are about 6–8 Angstroms, preferably about 7 Angstroms apart and the rigid amino acid is covalently bound to the support via the amino group of the amino acid.
REFERENCES:
patent: 3943245 (1976-03-01), Silverstein
patent: 1727839 (1992-04-01), None
patent: 90/09238 (1990-08-01), None
patent: 94/00483 (1994-01-01), None
Masahiro Iwamoto, “Plasminogen-Plasmin System IX. Specific Binding of Tranexamic Acid to Plasmin” 1975, pp. 573-585, XP-001021276.
Leonard A. Moroz et al., “Fibrinolysis in Normal Plasma and Blood: Evidence for Significant Mechanisms Independent of the Plasminogen-Plasmin System”, Blood, vol. 48, No. 4 (Oct. 1976), pp. 531-545, XP-001029014.
Azachi Malkit
Bar Liliana
Nur Israel
Jacobson & Holman PLLC
Omrix Biopharmaceuticals Inc.
Saucier Sandra E.
LandOfFree
Removal of plasmin(ogen) from protein solutions does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Removal of plasmin(ogen) from protein solutions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Removal of plasmin(ogen) from protein solutions will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3684450